States seek to expand lawsuit against generic drugmakers
November 1, 2017
HARTFORD, Conn. (AP) — Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drugmakers to include more manufacturers and medications, as well as senior executives at two companies.
Led by Connecticut, the states sought a federal court's permission Tuesday to widen their complaint, which alleges a number of illegal agreements among 18 manufacturers to fix prices and divvy up the market for specific generic drugs including treatments for high blood pressure, arthritis and asthma.
Mylan N.V., one of the drugmakers named in the s...
For access to this article please
sign in or
subscribe.
Reader Comments(0)